Clinical Trial Update: Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of aerosolized Colimycin in patients with cystic fibrosis has completed, evaluating lung and systemic exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Colimycin (colistin)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED